Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Biocon Limited
Press Release Oct 23 2025
Business
Oct 23 2025
3 min read

Press Release Oct 23 2025

Biocon Limited has informed the Exchange regarding a press release dated October 23, 2025, titled "Biocon Biologics Receives Health Canada Approval for Yesintek and Yesintek I.V. (ustekinumab), a Biosimilar to Stelara®".

View Attachment